NCT03847571 (AZ) is a clinical trial of Acetazolamide in Bartter Syndrome, sponsored by Tehran University of Medical Sciences.

Who is sponsoring NCT03847571?

NCT03847571 is sponsored by Tehran University of Medical Sciences.

What drugs are being tested in NCT03847571?

Interventions in NCT03847571: Acetazolamide.

What condition does NCT03847571 study?

NCT03847571 studies Bartter Syndrome.

Is NCT03847571 still recruiting?

NCT03847571 is currently status unknown. Last updated 20 February 2019.

Last reviewed 2019-02-20 · How we verify

NCT03847571: AZ

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acetazolamide (AZ) for Management of Alkalosis in Bartter Syndrome

Status unknown Last updated 20 February 2019

What this trial tests

trial testing Acetazolamide in Bartter Syndrome in 20 participants. Status unknown.

Timeline

10 January 2019

Primary endpoint
30 October 2019

30 December 2019

Quick facts

Lead sponsor	Tehran University of Medical Sciences
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	20
Start date	10 January 2019
Primary completion	30 October 2019
Estimated completion	30 December 2019
Sites	4 locations across Iran

Drugs / interventions tested

Acetazolamide (ACETAZOLAMIDE) — full drug profile →

Conditions studied

Bartter Syndrome — all drugs for Bartter Syndrome →

Sponsor

Tehran University of Medical Sciences

Who can join

Adults 1 to 10, any sex, with Bartter Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this prospective controlled cross over clinical trial, the investigators aim to evaluate the efficacy and safety of acetazolamide for the management of metabolic alkalosis in children with Bartter syndrome. Urine and blood electrolytes will be measured before and after acetazolamide treatment. The primary end point is a change in polyuria, hypokalemia, and metabolic alkalosis.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Bartter and Gitelman Syndromes: A Primer for Clinicians.
Nuñez-Gonzalez L, Carrera N, Garcia-Gonzalez MA. · · 2021 · cited 27× · PMID 34768847 · DOI 10.3390/ijms222111414
Advances in Diagnosis and Treatment of Inherited Kidney Diseases in Children.
Wang G, Liao M, Tan DJ, Chen X, et al · · 2024 · cited 1× · PMID 39664340 · DOI 10.1159/000541564

Verify or expand the search:

Other trials of Acetazolamide

Trials testing the same drug.

NCT07372040 — Add-on Diuretics in Acute Decompensated Heart Failure · Phase 2 · recruiting
NCT06945848 — Venous Stenting Evaluation in Patients With Intracranial Hypertension Under Long-term Acetazolamide · NA · recruiting
NCT07199088 — Comparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard Therapy in Patients With Ac · NA · recruiting
NCT03806751 — A Noninvasive Arterial Input Estimation Method for O-15 PET and Integrated PET/MR Scanning · EARLY_PHASE1 · withdrawn
NCT06166654 — Optimal Diuretic Therapies for Acute Heart Failure With Volume Overload · Phase 4 · recruiting

Other recruiting trials for Bartter Syndrome

Currently open trials in the same condition.

NCT06065852 — National Registry of Rare Kidney Diseases · recruiting

Other Tehran University of Medical Sciences trials

Trials by the same sponsor.

NCT07305883 — Comparison of Intranasal Ketorolac and Intranasal Ketamine in Digital Nerve Block Pain · Phase 3 · not yet recruiting
NCT06876194 — The Effect of Music on the Sedation Quality Among Children in the Emergency Department. · Phase 3 · completed
NCT06721273 — Iodine Supplementation and Fertility Parameters · NA · not yet recruiting
NCT07014397 — Effect of Valaciclovir on Inter-Appointment Pain in Endodontic Treatment of Necrotic Teeth · NA · completed
NCT06615934 — Effects of Aerobic and Resistance Exercises on Inpatients Liver Transplantation Recipients · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03847571 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tehran University of Medical Sciences
Last refreshed: 20 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03847571.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing